Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -3059.99% is 435% below its 5-year average of -571.78%, near the high end of its 5-year range (-12584.26%–0.00%).
1315.52% below its 12-month average of -216.17%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
-3059.99%
NET PROFIT MARGIN AVG TTM
-216.17%
NET PROFIT MARGIN AVG 3Y
-937.91%
NET PROFIT MARGIN AVG 5Y
-571.78%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-1315.52%
CURRENT VS 3Y AVG
-226.26%
CURRENT VS 5Y AVG
-435.17%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 622 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Immunome, Inc.
Market Cap
$1.93B
Net Profit Margin
-3059.99%
TTM Avg
-216.17%
3Y Avg
-937.91%
5Y Avg
-571.78%
Market Cap
$1.95B
Net Profit Margin
-15.82%
TTM Avg
-37.57%
3Y Avg
-42.30%
5Y Avg
-41.11%
Market Cap
$1.96B
Net Profit Margin
-13.36%
TTM Avg
-6.14%
3Y Avg
-11.71%
5Y Avg
-14.87%
Market Cap
$1.89B
Net Profit Margin
-20.02%
TTM Avg
-19.08%
3Y Avg
-29.38%
5Y Avg
-13.21%
Market Cap
$1.89B
Net Profit Margin
49.06%
TTM Avg
-18.57%
3Y Avg
-80.13%
5Y Avg
-53.74%
Market Cap
$1.87B
Net Profit Margin
-418.24%
TTM Avg
540.96%
3Y Avg
-464.63%
5Y Avg
-309.76%
Market Cap
$1.86B
Net Profit Margin
-59.87%
TTM Avg
5.85%
3Y Avg
-31.86%
5Y Avg
-479.70%
Market Cap
$2.00B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$2.00B
Net Profit Margin
100.84%
TTM Avg
51.96%
3Y Avg
-5.31%
5Y Avg
-103.82%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Immunome, Inc. (IMNM) | $1.93B | -3059.99% | -216.17% | -937.91% | -571.78% |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.95B | -15.82% | -37.57% | -42.30% | -41.11% |
| AxoGen, Inc. (AXGN)vs › | $1.96B | -13.36% | -6.14% | -11.71% | -14.87% |
| Azenta, Inc. (AZTA)vs › | $1.89B | -20.02% | -19.08% | -29.38% | -13.21% |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | 49.06% | -18.57% | -80.13% | -53.74% |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.87B | -418.24% | 540.96% | -464.63% | -309.76% |
| Novavax, Inc. (NVAX)vs › | $1.86B | -59.87% | 5.85% | -31.86% | -479.70% |
| Mineralys Therapeutics, Inc. (MLYS)vs › | $2.00B | 0.00% | 0.00% | 0.00% | 0.00% |
| Aurinia Pharmaceuticals Inc. (AUPH)vs › | $2.00B | 100.84% | 51.96% | -5.31% | -103.82% |
| Inspire Medical Systems, Inc. (INSP)vs › | $2.00B | 15.03% | 11.31% | 2.06% | -9.89% |
Operating Margin
-3084.8%
Net Profit Margin
-3060.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | -1080.87% |
| 2025-03-31 | -1423.10% |
| 2024-12-31 | -2930.93% |
| 2024-09-30 | -1618.56% |
| 2024-06-30 | -1528.00% |
| 2024-03-31 | -12584.26% |
| 2023-12-31 | -2421.17% |
| 2023-09-30 | -121.88% |
| 2023-06-30 | -130.35% |
| 2023-03-31 | -180.63% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
